戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g no medications; as well as between the two anticonvulsants.
2 tients had seizures, which were treated with anticonvulsants.
3           40 (5.6%) of 716 patients received anticonvulsants.
4  (p=0.26) was found among patients receiving anticonvulsants.
5 ng effects on block by local anesthetics and anticonvulsants.
6 ncephalopathies that are resistant to modern anticonvulsants.
7 -benzyl-2-acetamidoacetamides (2) are potent anticonvulsants.
8 tics, class I antiarrhythmic drugs, and some anticonvulsants.
9 sts for antipsychotics, antidepressants, and anticonvulsants.
10 lopmental quotient (DQ) > 30 did not require anticonvulsants.
11 ccupied by traditional local anesthetics and anticonvulsants.
12 nce seizure generation and responsiveness to anticonvulsants.
13  acting drugs, including antidepressants and anticonvulsants.
14 t spontaneous convulsions (>1 per hour) with anticonvulsants.
15 g-sensitive (BS) mutants as a tool to screen anticonvulsants.
16 by hypoxia can be refractory to conventional anticonvulsants.
17 logical conditions and is the target of some anticonvulsants.
18         Its pharmacology seems unaffected by anticonvulsants.
19 SSRIs and SNRIs; -0.91, -1.23 to -0.60), and anticonvulsants (-0.81, -1.36 to -0.28).
20 %), CCB (14.8% versus 14.4% versus 8.0%) and anticonvulsants (13.4% versus 7.7% versus 6.4%) with OR
21             Antibiotics (21.2%), followed by anticonvulsants (18.9%), nonsteroidal anti-inflammatory
22 h other opioid-involved overdose deaths (eg, anticonvulsants: 18.6% [95% CI, 17.0%-20.3%] vs 5.4% [95
23                                   The potent anticonvulsants 83a and 83j had greatly diminished carbo
24 to the hypothesis that lithium and antimanic anticonvulsants act by targeting parts of the "arachidon
25            Adults not taking enzyme-inducing anticonvulsants after resection or biopsy of GBM were tr
26 i); and Bn, Et (7j)] are also very effective anticonvulsants against seizures induced by maximal elec
27 psychotropic classes (e.g., antidepressants, anticonvulsants), although they may be safer options.
28 ues in patients treated with enzyme-inducing anticonvulsants, although this did not reach statistical
29                               Treatment with anticonvulsants and age were associated with greater odd
30                           The sensitivity to anticonvulsants and anesthetics of Ca(2+) currents arisi
31 r many clinically used inhibitors, including anticonvulsants and antiarrhythmics.
32        Evidence supports the use of specific anticonvulsants and antidepressants for pain management
33 ly important compounds, including diuretics, anticonvulsants and antidepressants, many of which have
34  Specifics of DPT to proton pump inhibitors, anticonvulsants and corticosteroids are discussed.
35 ation suggest that concurrent treatment with anticonvulsants and dexamethasone enhances drug clearanc
36 er combinations appear to be the mixtures of anticonvulsants and lithium, particularly valproate plus
37 sts that could have therapeutic potential as anticonvulsants and neuroprotectants.
38 rmined that the recommendations from the CNS anticonvulsants and steroids guidelines, published Janua
39  drugs with a focus on the controlled use of anticonvulsants and steroids.
40 on-beta-lactam antimicrobials, 9 (6.0%) were anticonvulsants, and 5 (3.3%) were calcium channel block
41 ceptor are important anesthetics, sedatives, anticonvulsants, and anxiolytics.
42 es occur frequently, are often refractory to anticonvulsants, and are associated with considerable mo
43           Clinicians should utilize omega-3, anticonvulsants, and atypical antipsychotic agents in tr
44 low-potency phenothiazines, lithium, certain anticonvulsants, and benzodiazepines may increase the re
45 inistration of uterotonics, antibiotics, and anticonvulsants, and clean birth environments) would acc
46 mptomatic treatment with corticosteroids and anticonvulsants, and definitive therapy in the form of w
47 asses of clinical agents (e.g., anxiolytics, anticonvulsants, and general anesthetics) that act as po
48 inhibitors, cinchona alkaloids, antibiotics, anticonvulsants, and heparin.
49                   Phenylalanine, teratogenic anticonvulsants, and high concentrations of glucose did
50 t is potentiated by widely used anxiolytics, anticonvulsants, and hypnotics.
51 etrovirals, antidepressants, antipsychotics, anticonvulsants, and immunosuppressants for transplant p
52  neurological symptoms, with gabapentin-type anticonvulsants, and is among the first in nonepileptic
53 hotics for schizophrenia and antipsychotics, anticonvulsants, and lithium for bipolar disorder.
54                             Antiarrhythmics, anticonvulsants, and local anesthetics target voltage-ga
55 r-bipolar subtype (N = 15) for whom lithium, anticonvulsants, and neuroleptics had been ineffective,
56 Barbiturates are widely used as anesthetics, anticonvulsants, and neuroprotective agents.
57 sychotics, benzodiazepines, antidepressants, anticonvulsants, and opioids followed the onset of the C
58 reatments include tricyclic antidepressants, anticonvulsants, and opioids, depending on the severity
59  Their therapeutic potential as anxiolytics, anticonvulsants, and sedative/hypnotics is limited by ra
60 rugs and contraceptives are rare, clozapine, anticonvulsants, and St.
61 also important drug targets for anxiolytics, anticonvulsants, antidepressants, and anesthetics.
62 n prescriptions (analgesics or antipyretics, anticonvulsants, antidepressants, and nonsteroidal anti-
63 utic drugs and supportive-care drugs-such as anticonvulsants, antiemetics, uric-acid-lowering compoun
64 esthetics, antiarrhythmics, antidepressants, anticonvulsants, antihistamines, antihypertensives, anti
65 17-3.81; P for trend < .001), whereas use of anticonvulsants, antipsychotics, or antidepressants was
66 ulate GABAA receptors have potential uses as anticonvulsants, anxiolytics, and sedative-hypnotic agen
67            Therefore, new and more effective anticonvulsants are continually sought after to combat t
68                                        These anticonvulsants are neutral, in contrast to the mostly p
69                               Broad-spectrum anticonvulsants are of considerable interest as antiepil
70        Maintenance treatment with lithium or anticonvulsants as practiced in modern care is associate
71            PURPOSE OF REVIEW: Despite myriad anticonvulsants available and in various stages of devel
72 ochloride (B = 0.033; SE = 0.010; P < .001), anticonvulsants (B = 0.014; SE = 0.006; P = .03), and op
73 s to specific treatments, including sedative anticonvulsants (barbiturates and benzodiazepines) and E
74 ney disease, or diabetes and subjects taking anticonvulsants, barbiturates, or steroids.
75 de: antidepressants, anti-adrenergic agents, anticonvulsants, benzodiazepines, atypical antipsychotic
76         Drug repurposing analysis identified anticonvulsants, beta-blockers and calcium-channel block
77 dditional commonly used Na(+) channel-acting anticonvulsants, both in control and epileptic animals.
78 se findings advance the development of novel anticonvulsants by validating an influence of alkyl chai
79        Systemic antibiotics, antivirals, and anticonvulsants can trigger adverse reactions that may i
80 ies and other risk factors, among individual anticonvulsants compared with topiramate and secondarily
81                      We investigated whether anticonvulsants compromise the efficacy of cancer chemot
82 .80-3.42; P for trend < .001), as was use of anticonvulsants (definite CKD, 1-2 prescriptions: HR = 1
83 unds represent novel leads in the search for anticonvulsants devoid of sedative, ataxic, and amnestic
84 ic and clinical seizures with currently used anticonvulsants did not significantly reduce the rate of
85 a is provided by modern antipsychotics, some anticonvulsants (divalproex and carbamazepine), and lith
86 rograms, placebo, opioids, psychostimulants, anticonvulsants, dopamine agonists, antidepressants, ant
87 zyl-3-ethyl lactam 7j are the most effective anticonvulsants (ED50 = 46 and 42 mg/kg, respectively) a
88 s included antiinfectives (eg, fluconazole), anticonvulsants (eg, valproate), antihypertensives (eg,
89 d in patients receiving p450 enzyme-inducing anticonvulsants (EIACs) by 73%, 47%, and 50%, respective
90 aging or EEG), prophylactic antipyretics and anticonvulsants far outweigh their potential benefits.
91 sia and eclampsia; and short-term parenteral anticonvulsants for seizures associated with encephalopa
92                                     Although anticonvulsants have proven very helpful in treating sei
93  anakinra if the response is inadequate, and anticonvulsants if convulsions occur.
94 ncy O-methylated analogue 18 are both potent anticonvulsants in a mouse maximal electroshock-induced
95 ll have surprisingly high in vivo potency as anticonvulsants in a mouse maximal electroshock-induced
96 ) derivatives were prepared and evaluated as anticonvulsants in mice.
97 in are equally but incompletely effective as anticonvulsants in neonates.
98 ge underlying precipitant causes, administer anticonvulsants in rapid succession until seizures have
99 ation, and for prophylactic antipyretics and anticonvulsants, in the majority of children with simple
100                          Lithium and certain anticonvulsants, including carbamazepine and valproic ac
101 onatal seizures do not respond to first-line anticonvulsants, including phenobarbital, which enhances
102  the most teratogenic of commonly prescribed anticonvulsants, increasing the risk in humans of major
103 ds, acetaminophen, anti-inflammatory agents, anticonvulsants, ketamine, clonidine, mexiletine, antide
104 o change treatment to one of the noninducing anticonvulsants lamotrigine or levetiracetam.
105 re antidepressants, atypical antipsychotics, anticonvulsants, lithium, and other medications used in
106 pregnancy and that increasing doses of these anticonvulsants may be needed throughout the course of p
107 ior, in addition to concerns that the use of anticonvulsants may increase self-harm.
108 ts exposed to either lithium (n = 26,731) or anticonvulsants (n=420,959).
109                      Some drugs developed as anticonvulsants (notably, valproate and lamotrigine) hav
110 sed to assess the prognostic significance of anticonvulsants on event-free survival and risk of haema
111 sychotics, benzodiazepines, antidepressants, anticonvulsants, opioids, antibiotics, angiotensin recep
112 ds for chronic noncancer pain, compared with anticonvulsants or cyclic antidepressants, was associate
113  for long-acting opioids or either analgesic anticonvulsants or low-dose cyclic antidepressants (cont
114 ity under anesthesia, but clinical trials of anticonvulsants or neural system suppressors have, so fa
115 ) or were nonambulatory and either receiving anticonvulsants or not; all had developmental delays.
116  but no cross-reactivity was seen with other anticonvulsants or structural analogs.
117 psychotics, combinations of antidepressants, anticonvulsants, or "other") for >/=60 consecutive days
118 , which was similar to that observed for the anticonvulsants phenytoin (slowly binds to the fast-inac
119                        The widely prescribed anticonvulsants phenytoin and carbamazepine are potent i
120 eceived treatment for 30 days or longer with anticonvulsants (phenytoin, phenobarbital, carbamazepine
121                                 Conventional anticonvulsants reduce neuronal excitability through eff
122              Alternatives to enzyme-inducing anticonvulsants should be prescribed for patients receiv
123 ng at very high rates, suggesting that these anticonvulsants should cause impaired GABAergic inhibiti
124 TCAs (SMD, -0.78 [CrI, -1.24 to -0.33]), and anticonvulsants (SMD, -0.67 [CrI, -0.97 to -0.37]) were
125 epinephrine reuptake inhibitors (SNRIs) than anticonvulsants (standardized mean difference [SMD], -0.
126 ng-term relapse prevention; the evidence for anticonvulsants such as divalproex and lamotrigine is le
127 lectroencephalographic response to GABAergic anticonvulsants such as phenobarbital and benzodiazepine
128 eclude the efficacy of widely used GABAergic anticonvulsants such as phenobarbital.
129  includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, and
130                                      Current anticonvulsants target gamma-aminobutyric acid type A re
131 CBZ) and oxcarbazepine (OXC) are widely used anticonvulsants that are extensively metabolized in the
132  activity in the cortex is not suppressed by anticonvulsants that block the transmission of seizure a
133 tribute to resistance of seizure activity to anticonvulsants that increase GABAergic function, and ma
134 two of which are approved for human use, are anticonvulsants that modulate neural activity.
135                                As a class of anticonvulsants, the 3,3-disubstituted 2-pyrrolidinones
136                                   Except for anticonvulsants, the adjusted risks for all individual c
137 des because of the increased availability of anticonvulsants, the ketogenic diet has re-emerged as a
138 yl-N'-(4-methoxynaphth-1-yl)guanidine (3) as anticonvulsants through blockade of sodium channels.
139  is to stop the seizures quickly enough with anticonvulsants to prevent brain damage.
140                    In seeking broad-spectrum anticonvulsants to treat epilepsy and other neurological
141 f the pandemic period ranged from 0.48% (for anticonvulsants) to 1.52% (for antipsychotics).
142 to treatment with tricyclic antidepressants, anticonvulsants (topiramate), coenzyme Q-10, and L-carni
143 differences in sex distribution or number of anticonvulsants used between patients with bruising/blee
144 , attempted suicides, and violent deaths for anticonvulsants used in at least 100 treatment episodes
145 tly on lithium and to a lesser extent on the anticonvulsants valproate and lamotrigine.
146  illness, use of antidepressants, and use of anticonvulsants versus lithium.
147 reased rate of end-stage CKD, whereas use of anticonvulsants was (1-2 prescriptions, HR = 0 [95% CI,
148 ,5-diones as potential broad-spectrum hybrid anticonvulsants was described.
149 rtication at age 8.5 years and withdrawal of anticonvulsants when he was more than 9 years old, Alex
150 nonketotic hyperglycinemia required multiple anticonvulsants, whereas patients with developmental quo
151 ribute an important component to binding for anticonvulsants, which compensates energetically for the
152 ical conditions, such as antidepressants and anticonvulsants, which were found empirically to be effe
153  compound was directed to identifying potent anticonvulsants with a long duration of action and a fav
154 tassium channels, we have docked these three anticonvulsants with residues identified by mutagenesis
155 eatment step and a higher cumulative dose of anticonvulsants within the first period of treatment wer
156 mnolence and dizziness with TCAs, SNRIs, and anticonvulsants; xerostomia with TCAs; and peripheral ed
157  have a long history of use as folk medicine anticonvulsants, yet the underlying mechanisms often rem

 
Page Top